Related Experiment Video
Updated: Jun 14, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Ejaculatory dysfunction in patient with schizophrenia on sertindole.
Marija Kusan Jukić1, Stipe Drmić, Ninoslav Mimica
1Psychiatric Hospital Vrapce, Bolnicka cesta 32, HR-10090 Zagreb, Croatia.
Psychiatria Danubina
|March 23, 2010
Summary
Antipsychotic medications for psychotic disorders can cause sexual dysfunction. Reducing the dose of sertindole in a schizophrenia patient significantly improved ejaculatory dysfunction, highlighting dose-dependency of side effects.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Antipsychotic medications are crucial for managing psychotic disorders but are linked to adverse effects.
- Sexual dysfunction is a significant concern for patients with psychotic disorders, often more prevalent with medication than the untreated condition.
Observation:
- A patient with chronic schizophrenia treated with sertindole experienced ejaculatory dysfunction.
- This sexual side effect was noted to be dose-dependent.
Findings:
- Reducing the dosage of sertindole led to a significant amelioration of the ejaculatory dysfunction.
- This case highlights the importance of considering drug dosage in managing antipsychotic-induced sexual side effects.
Implications:
- Clinicians should consider dose reduction as a strategy for managing sexual dysfunction in patients on antipsychotics.
- Individualized risk-benefit assessments are essential when deciding on antipsychotic treatment adjustments for adverse effects.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:30Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...